Cargando…

Gasdermin: a novel therapeutic target for tumour treatment by activating anti-tumour immunity

Detalles Bibliográficos
Autor principal:	Fu, Caiyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220934/ https://www.ncbi.nlm.nih.gov/pubmed/32404864 http://dx.doi.org/10.1038/s41392-020-0180-4

Ejemplares similares

Novel pyroptosis-independent functions of gasdermins
por: Qin, Ziran, et al.
Publicado: (2022)

B-cell immune checkpoint TIM-1: a potential target for tumour immunotherapy
por: Tian, Xinyu, et al.
Publicado: (2023)

Gasdermin D as a cellular switch to orientate immune responses via IL-33 or IL-1β
por: Chauvin, Camille, et al.
Publicado: (2022)

Prokaryotic gasdermins: ancestors of eukaryotic counterparts direct the pyroptosis and cell fates
por: Liu, Yingying, et al.
Publicado: (2022)

Caspase-7 and acid sphingomyelinase: partner repairmans of gasdermin and perforin pores
por: Jin, Ke, et al.
Publicado: (2022)

Tumour travel tours – Why circulating cancer cells value company
por: Häfner, Sophia Julia
Publicado: (2020)

Targeting B cells and plasma cells in autoimmune diseases: From established treatments to novel therapeutic approaches
por: Merino‐Vico, Ana, et al.
Publicado: (2022)

Porous insights: IpaH7.8 reveals crystal-clear differences of gasdermins in mice and men
por: von Samson-Himmelstjerna, Friedrich Alexander, et al.
Publicado: (2023)

In search for novel strategies towards neuroprotection and neuroregeneration: is PPARα a promising therapeutic target?
por: Moreno, Sandra, et al.
Publicado: (2015)

Circadian‐rhythm‐regulating hormones: Key factors to regulate breast cancer metastasis via circulating tumor cells
por: Liu, Chenguang, et al.
Publicado: (2022)

Lactate-avid regulatory T cells: metabolic plasticity controls immunosuppression in tumour microenvironment
por: Multhoff, Gabriele, et al.
Publicado: (2021)

Cytotoxic FCER1G(+) innate-like T cells: new potential for tumour immunotherapy
por: Morrish, Emma, et al.
Publicado: (2022)

Innate immune signaling and immunothrombosis: New insights and therapeutic opportunities
por: Ryan, Tristram A. J., et al.
Publicado: (2022)

NLRP3 inflammasome as a novel therapeutic target for Alzheimer’s disease
por: Zhang, Yun, et al.
Publicado: (2020)

SERIneALanine Killer: SPT promiscuity inhibits tumour growth via intra-tumoral deoxysphingolipid production
por: Falcone, Mattia, et al.
Publicado: (2020)

Mitochondrial dysfunction and alcohol-associated liver disease: a novel pathway and therapeutic target
por: Abdallah, Mohamed A., et al.
Publicado: (2020)

An anti-tumor coup: TIM3 ablation activates the immune arsenal
por: Görgülü, Kıvanç, et al.
Publicado: (2021)

Targeting programmed death ligand 2/repulsive guidance molecule b pathway: a novel strategy to subdue tumor immunotherapy resistance to anti‐programmed death 1/programmed death ligand 1
por: Xiang, Yuancai, et al.
Publicado: (2023)

LARGE enzyme activity deciphered: a new therapeutic target for muscular dystrophies
por: Hewitt, Jane E
Publicado: (2012)

Janus kinase signaling as risk factor and therapeutic target for severe SARS‐CoV‐2 infection
por: Solimani, Farzan, et al.
Publicado: (2021)

Gasdermin E suppresses tumor growth by activating anti-tumor immunity
por: Zhang, Zhibin, et al.
Publicado: (2020)

A novel “complement–metabolism–inflammasome axis” as a key regulator of immune cell effector function
por: Arbore, Giuseppina, et al.
Publicado: (2016)

Lymphatic metastasis in non‐small cell lung cancer: recent discoveries and novel therapeutic targets
por: Diao, Xiayao, et al.
Publicado: (2022)

Identifying therapeutic targets for schizophrenia
por: Montague-Cardoso, Karli
Publicado: (2021)

Prevention and treatment of COVID‐19 disease by controlled modulation of innate immunity
por: Schijns, Virgil, et al.
Publicado: (2020)

Age-induced changes in lung microenvironment: from melanoma dormancy to outgrowth
por: Jin, Juan, et al.
Publicado: (2023)

Hydrogen sulfide controls peripheral nerve degeneration and regeneration: a novel therapeutic strategy for peripheral demyelinating disorders or nerve degenerative diseases
por: Jung, Junyang, et al.
Publicado: (2014)

Apaf-1/caspase-4 pyroptosome: a mediator of mitochondrial permeability transition-triggered pyroptosis
por: Shao, Gang, et al.
Publicado: (2021)

Single cell RNA and immune repertoire profiling of COVID-19 patients reveal novel neutralizing antibody
por: Li, Fang, et al.
Publicado: (2020)

‘Nur'turing tumor T cell tolerance and exhaustion: novel function for Nuclear Receptor Nur77 in immunity
por: Lith, Sanne C., et al.
Publicado: (2020)

Pharmacologic RNA splicing modulation: a novel mechanism to enhance neoantigen-directed anti-tumor immunity and immunotherapy response
por: Elliott, Kerryn, et al.
Publicado: (2021)

Human Tumour Immune Evasion via TGF-β Blocks NK Cell Activation but Not Survival Allowing Therapeutic Restoration of Anti-Tumour Activity
por: Wilson, Erica B., et al.
Publicado: (2011)

Fumarate hydratase inhibition activates innate immunity via mitochondrial nucleic acid release
por: Li, Xiang, et al.
Publicado: (2023)

ASGR1: an emerging therapeutic target in hypercholesterolemia
por: Zhao, Wenqi, et al.
Publicado: (2023)

Struggling to get a universal meningococcal vaccine and novel uses for bacterial toxins in cancer treatment
por: Daniels, Craig, et al.
Publicado: (2010)

Gasdermins and their role in immunity and inflammation
por: Orning, Pontus, et al.
Publicado: (2019)

MEOX1: a novel druggable target that orchestrates the activation of fibroblasts in cardiac fibrosis
por: Schumacher, David, et al.
Publicado: (2021)

Regulatory T cells as a therapeutic approach for inflammatory bowel disease
por: Laukova, Marcela, et al.
Publicado: (2023)

EDS1 modules as two-tiered receptor complexes for TIR-catalyzed signaling molecules to activate plant immunity
por: Li, Jia, et al.
Publicado: (2022)

Inhibition of tumor autophagy: a strategy to improve anti-tumor immunity?
por: Freeman, Andrew J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_aqgfv084eb6u3ou2ghfghagp2r